These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2225536

  • 1. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments.
    Broby-Johansen U, Karlsmark T, Petersen LJ, Serup J.
    Clin Exp Dermatol; 1990 Sep; 15(5):343-8. PubMed ID: 2225536
    [Abstract] [Full Text] [Related]

  • 2. Antipsoriatic effect of local corticosteroids--O2-consumption and blood flow measurements compared to clinical parameters.
    Broby-Johansen U, Kristensen JK.
    Clin Exp Dermatol; 1989 Mar; 14(2):137-40. PubMed ID: 2689017
    [Abstract] [Full Text] [Related]

  • 3. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
    van der Vleuten CJ, van Vlijmen-Willems IM, de Jong EM, van de Kerkhof PC.
    Arch Dermatol Res; 1999 Mar; 291(7-8):390-5. PubMed ID: 10482007
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis.
    Kragballe K, Larsen FG.
    Acta Derm Venereol; 1991 Mar; 71(6):540-2. PubMed ID: 1685841
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
    Mommers JM, van Erp PE, van De Kerkhof PC.
    Dermatology; 1999 Mar; 199(4):323-7. PubMed ID: 10640842
    [Abstract] [Full Text] [Related]

  • 9. Treatment of psoriasis with triamcinolone acetonide 0.1% under occlusion: a comparison of two hydrocolloid dressings.
    González JR, Cabán F.
    Bol Asoc Med P R; 1990 Jul; 82(7):288-91. PubMed ID: 2261015
    [Abstract] [Full Text] [Related]

  • 10. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G, Kragballe K, Van De Kerkhof PC, Aberg K, White RJ.
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [Abstract] [Full Text] [Related]

  • 11. Treatment of hand dermatosis: a comparative study of a topical glucocorticoid ointment vs solution occluded with a new thin hydrocolloid dressing.
    Beitner H.
    Acta Derm Venereol; 1996 Sep; 76(5):408-9. PubMed ID: 8891026
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
    Naldi L, Yawalkar N, Kaszuba A, Ortonne JP, Morelli P, Rovati S, Mautone G.
    Am J Clin Dermatol; 2011 Jun 01; 12(3):191-201. PubMed ID: 21284407
    [Abstract] [Full Text] [Related]

  • 13. Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
    Zackheim HS, Kashani-Sabet M, Amin S.
    Arch Dermatol; 1998 Aug 01; 134(8):949-54. PubMed ID: 9722724
    [Abstract] [Full Text] [Related]

  • 14. The value of colloid dressings in psoriasis.
    Agius A, Borg E, Pace JL.
    Adv Exp Med Biol; 1999 Aug 01; 455():377-85. PubMed ID: 10599373
    [Abstract] [Full Text] [Related]

  • 15. Treatment of psoriasis and other dermatoses with a single application of a corticosteroid left under a hydrocolloid occlusive dressing for one week.
    Juhlin L.
    Acta Derm Venereol; 1989 Aug 01; 69(4):355-7. PubMed ID: 2568063
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of topical antipsoriatic treatment by chromametry, visiometry and 20-MHz ultrasound in the psoriasis plaque test.
    Bangha E, Elsner P.
    Skin Pharmacol; 1996 Aug 01; 9(5):298-306. PubMed ID: 8990504
    [Abstract] [Full Text] [Related]

  • 17. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
    Swinkels OQ, Prins M, Kucharekova M, de Boo T, Gerritsen MJ, van der Valk PG, van de Kerkhof PC.
    Br J Dermatol; 2002 Apr 01; 146(4):621-6. PubMed ID: 11966693
    [Abstract] [Full Text] [Related]

  • 18. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
    Norris JF, Ilderton E, Yardley HJ, Summerly R, Forster S.
    Br J Dermatol; 1984 Jul 01; 111 Suppl 27():195-203. PubMed ID: 6743552
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment.
    Glade CP, van der Vleuten CJ, van Erp PE, van de Kerkhof PC.
    Skin Pharmacol Appl Skin Physiol; 2002 Jul 01; 15(2):92-9. PubMed ID: 11867965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.